Bromadoline is a synthetic opioid-like compound with potential analgesic and anxiolytic properties. It was first developed in the 1980s and has since been studied for its ability to alleviate pain and anxiety in animal models. As of yet, it has not been approved for human use and is classified as a research chemical.
Chemical Name:
Bromadoline's chemical name is 3-(p-bromoanilino)-2-(N,N-di-n-propylamino)propanamide.
Molecular Formula:
The molecular formula for Bromadoline is C18H30BrN3O.
Formula Weight:
The formula weight of Bromadoline is 398.366 g/mol.
CAS No:
Bromadoline's CAS number is 67579-24-2.
Top Ten Keywords from Google and Synonyms:
Health Benefits of Bromadoline:
Bromadoline has not been approved for human use and is not currently available as a prescription medication. However, it has been researched for its potential therapeutic uses, including analgesia (pain relief) and anxiolysis (reduced anxiety).
Potential Effects:
Bromadoline's potential effects are largely based on animal studies and have not been well-studied in humans. Preclinical studies have suggested that Bromadoline may be effective in reducing pain and anxiety, though further research is needed.
Product Mechanism:
Bromadoline acts on both the opioid and serotoninergic systems in the brain, which contributes to its potential analgesic and anxiolytic effects. It is believed to bind to opioid receptors in the central nervous system, like other common opioids such as morphine and fentanyl, and also modulate serotonin release in the brain.
Safety:
Bromadoline has not been approved for human use and therefore has not undergone rigorous safety testing that is required for prescription medications. However, preclinical studies have given some insight into its potential safety profile. It has been found to have lower respiratory depression compared to other opioids such as morphine and fentanyl. There is also a risk of toxicity at high concentrations.
Side Effects:
As with most opioids, the most common side effects associated with Bromadoline use are nausea, vomiting, constipation, drowsiness, and respiratory depression. At high doses, there is a risk of toxicity, which can cause more severe respiratory depression and potentially fatal outcomes.
Dosing Information:
Bromadoline is not approved for human use, and therefore, dosing information is not available. As a research chemical, its use is typically limited to laboratory settings, where it is used to study its potential therapeutic effects.
Conclusion:
Bromadoline is a synthetic opioid-like compound with potential analgesic and anxiolytic properties. While it has been studied in animal models, it has not been approved for human use due to its potential toxic effects at higher doses. As a result, its safety and use in human patients are not clearly understood. Nevertheless, research in this area continues, as there is a need for novel analgesic and anxiolytic agents with fewer undesirable effects. Careful consideration and research are necessary to advance our understanding of Bromadoline or any similar compound for therapeutic use in humans.
